189 studies found for:    Open Studies | "Blood Platelet Disorders"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Thrombocytopathy in Gaucher Disease Patients
Conditions: Gaucher Disease;   Thrombocytopathy
Intervention:
2 Not yet recruiting Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder
Condition: Inherited Platelet Disorders
Intervention: Other: Blood collection for platelet protein samples
3 Not yet recruiting Comparison of the Effects of Gelatine Versus Balanced Crystalloid Solution for Volume Therapy
Conditions: Hemorrhage, Surgical;   Hip Replacement, Total;   Thrombocytopathy
Interventions: Drug: Gelofusine® B. Braun;   Drug: Ringerfundin ® B. Braun
4 Unknown  Safety and Efficacy of Eltrombopag at Escalated Doses
Conditions: Immune Thrombocytopenia;   Platelet Disorder
Interventions: Drug: Eltrombopag;   Drug: Placebo
5 Recruiting Eltrombopag for Inherited Thrombocytopenias
Condition: Inherited Platelet Disorder
Intervention: Drug: Eltrombopag
6 Recruiting ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP
Condition: Immune Thrombocytopenia
Intervention: Drug: Second Line ITP agents
7 Recruiting Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures
Condition: Platelet Dysfunction
Intervention: Drug: desmopressin
8 Unknown  Evaluation of a New Approach of the Diagnosis of Constitutional Functional Disorders of Platelets
Condition: Platelet Dysfunction
Intervention: Other: Blood punction
9 Recruiting Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy
Conditions: Lung Adenocarcinoma;   Neutropenia;   Anemia;   Thrombocytopenia;   Nonsquamous Nonsmall Cell Neoplasm of Lung
Intervention: Dietary Supplement: Folate and B12
10 Not yet recruiting Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders
Conditions: Myeloproliferative Disorders;   Polycythemia Vera;   Essential Thrombocythemia;   Myelofibrosis;   Chronic Myeloid Leukemia
Intervention:
11 Not yet recruiting Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Rituximab;   Drug: Dexamethasone;   Drug: Mycophenolate mofetil;   Drug: Placebo
12 Recruiting Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Interventions: Drug: Dexamethasone (4 cycles);   Drug: Dexamethasone (1 cycle)
13 Not yet recruiting Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia
Conditions: Adult Immune Thrombocytopenia (ITP);   Dapsone
Interventions: Drug: Dapsone (Disulone®);   Drug: Prednisone (Cortancyl®) alone followed by monitoring and "standard of care";   Drug: Prednisone (Cortancyl®)
14 Not yet recruiting The Role of Microparticles as a Biomarker
Conditions: Atypical Hemolytic Uremic Syndrome;   Thrombotic Thrombocytopenic Purpura;   Microparticles;   Microangiopathic Hemolytic Anemia
Intervention:
15 Recruiting Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Chronic Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Hetrombopag Olamine
16 Not yet recruiting Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia
Conditions: MPN;   Essential Thrombocythemia
Interventions: Other: Aspirin therapy interruption;   Other: Usual treatment by aspirin 100 mg/d in the active comparator arm;   Other: No interruption of aspirin in the Observational arm;   Drug: Hydroxyurea treatment (HU)
17 Not yet recruiting Minimize Menorrhagia in Women With Type 1 Von Willebrand Disease
Condition: Type 1 Von Willebrand Disease
Interventions: Drug: recombinant von Willebrand factor;   Drug: tranexamic acid
18 Recruiting Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants
Conditions: Thrombotic Microangiopathy;   Disorder Related to Bone Marrow Transplantation
Intervention: Drug: eculizumab
19 Not yet recruiting A Phase II Non-Controlled, Open-Label, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Pacritinib in Myelofibrosis
Condition: Primary Myelofibrosis
Intervention: Biological: Pacritinib
20 Not yet recruiting American Trial Using Tranexamic Acid in Thrombocytopenia
Condition: Thrombocytopenia
Interventions: Drug: Tranexamic Acid;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years